摘要
Since autophagy and the immune microenvironment are deeply involved in the tumor development and progression of Lower-grade gliomas (LGG), our study aimed to construct an autophagy-related risk model for prognosis prediction and investigate the relationship between the immune microenvironment and risk signature in LGG. Therefore, we identified six autophagy-related genes (BAG1, PTK6, EEF2, PEA15, ITGA6, and MAP1LC3C) to build in the training cohort (n = 305 patients) and verify the prognostic model in the validation cohort (n = 128) and the whole cohort (n = 433), based on the data from The Cancer Genome Atlas (TCGA). The six-gene risk signature could divide LGG patients into high- and low-risk groups with distinct overall survival in multiple cohorts (all p < 0.001). The prognostic effect was assessed by area under the time-dependent ROC (t-ROC) analysis in the training, validation, and whole cohorts, in which the AUC value at the survival time of 5 years was 0.837, 0.755, and 0.803, respectively. Cox regression analysis demonstrated that the risk model was an independent risk predictor of OS (HR > 1, p < 0.05). A nomogram including the traditional clinical parameters and risk signature was constructed, and t-ROC, C-index, and calibration curves confirmed its robust predictive capacity. KM analysis revealed a significant difference in the subgroup analyses' survival. Functional enrichment analysis revealed that these autophagy-related signatures were mainly involved in the phagosome and immune-related pathways. Besides, we also found significant differences in immune cell infiltration and immunotherapy targets between risk groups. In conclusion, we built a powerful predictive signature and explored immune components (including immune cells and emerging immunotherapy targets) in LGG.
学科与关键词
- Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiformeWang, Jinghua; Qiu, Xinqi; Huang, Jiayu; Zhuo, Zewei; Chen, Hao; Zeng, Ruijie; Wu, Huihuan; Guo, Kehang; Yang, Qi; Ye, Huiling*; Huang, Wei*; Luo, Yujun*BMC CANCER, 2022, 22(1): 644.被引 6
- Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With GliomaZhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng*Frontiers in Genetics, 2022, 13: 899125.被引 2
- Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade GliomaYan, Xiuwei; Ji, Hang; Liu, Zhihui; Ma, Shuai; Dong, Jiawei; Jiang, Xiaoyan; Hu, Xueyan; Wang, Fang; Zhao, Hongtao; Jin, Jiaqi; Zhang, Jiheng; Wang, Nan; Du, Jianyang*; Hu, Shaoshan*Frontiers in Genetics, 2022, 13: 880864.被引 1
